| 5TRU: reference: Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab., Ramagopal UA, Liu W, Garrett-Thomson SC, Bonanno JB, Yan Q, Srinivasan M, Wong SC, Bell A, Mankikar S, Rangan VS, Deshpande S, Korman AJ, Almo SC, Proc Natl Acad Sci U S A. 2017 May 8. pii: 201617941. doi:, 10.1073/pnas.1617941114. PMID: 28484017 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).